カテゴリ： MarketLine, アメリカ, 企業調査

Assertio Therapeutics Inc：企業の戦略・SWOT・財務分析

◆英語タイトル：Assertio Therapeutics Inc - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY4580
◆発行会社（調査会社）：MarketLine
◆発行日：2020年2月
◆ページ数：46
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：Pharmaceuticals and Healthcare
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Assertio Therapeutics Inc – Strategy, SWOT and Corporate Finance Report
Summary

Assertio Therapeutics Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Assertio Therapeutics Inc (Assertio), formerly Depomed Inc, is a specialty pharmaceutical company that develops and commercializes drugs for the treatment of pain and other diseases of central nervous system. Its product portfolio comprises drugs for the treatment of postherpetic neuralgia caused by viral infection, herpes zoster, or nerve damage; management of mild to moderate acute pain in adults; migraine attacks in adults of 18 years of age or above; and pain in cancer patients of 18 years of age and older. The company sells its products to wholesale distributors and retail pharmacies. Assertio also licenses Acuform, its proprietary gastroretentive drug delivery technology. Assertio is headquartered in Lake Forest, Illinois, the US.

Scope

- Detailed information on Assertio Therapeutics Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Assertio Therapeutics Inc in the form of a SWOT analysis
- An in-depth view of the business model of Assertio Therapeutics Inc including a breakdown and examination of key business segments
- Intelligence on Assertio Therapeutics Inc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Assertio Therapeutics Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Assertio Therapeutics Inc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Assertio Therapeutics Inc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Assertio Therapeutics Inc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Assertio Therapeutics Inc: Company Overview
Assertio Therapeutics Inc: Overview and Key Facts
Assertio Therapeutics Inc: Overview
Assertio Therapeutics Inc: Key Facts
Assertio Therapeutics Inc: Key Employees
Assertio Therapeutics Inc: Key Employee Biographies
Assertio Therapeutics Inc: Major Products and Services
Assertio Therapeutics Inc: Company History
Assertio Therapeutics Inc: Management Statement
Assertio Therapeutics Inc: Locations and Subsidiaries
Assertio Therapeutics Inc: Key Competitors
Assertio Therapeutics Inc: Company Analysis
Assertio Therapeutics Inc: Business Description
Assertio Therapeutics Inc: SWOT Analysis
Assertio Therapeutics Inc: SWOT Overview
Assertio Therapeutics Inc: Strengths
Assertio Therapeutics Inc: Weaknesses
Assertio Therapeutics Inc: Opportunities
Assertio Therapeutics Inc: Threats
Assertio Therapeutics Inc: Corporate Financial Deals Activity
Assertio Therapeutics Inc: Financial Deals Overview
Assertio Therapeutics Inc: Top Deals 2016 – 2020YTD*
Assertio Therapeutics Inc: Advisors
Assertio Therapeutics Inc: Top Legal Advisors
Assertio Therapeutics Inc: Top Financial Advisors
Assertio Therapeutics Inc: Mergers and Acquisitions
Assertio Therapeutics Inc: Partnership
Assertio Therapeutics Inc: Divestments
Assertio Therapeutics Inc: Recent Developments
Assertio Therapeutics Inc: News and Events Summary
Assertio Therapeutics Inc: Business Expansion
Assertio Therapeutics Inc: Corporate Governance
Assertio Therapeutics Inc: Financial Performance
Assertio Therapeutics Inc: Regulatory and Legal Events
Assertio Therapeutics Inc: Research & Development
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Assertio Therapeutics Inc: Key Facts
Table 2: Assertio Therapeutics Inc: Key Employees
Table 3: Assertio Therapeutics Inc: Company History
Table 4: Assertio Therapeutics Inc: Locations and Subsidiaries
Table 5: Assertio Therapeutics Inc: Key Competitors
Table 6: Assertio Therapeutics Inc: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Assertio Therapeutics Inc: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Assertio Therapeutics Inc: M&A Average Deal Size - Value (US$m)
Table 9: Assertio Therapeutics Inc: Top Deals 2016 - 2020YTD*
Table 10: Assertio Therapeutics Inc: Legal Advisor Ranking by Value (US$m)
Table 11: Assertio Therapeutics Inc: Financial Advisor Ranking by Value (US$m)
Table 12: Assertio Therapeutics Inc: M&A Volume and Value Trend (2016 - YTD*2020)
Table 13: Assertio Therapeutics Inc: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 14: Assertio Therapeutics Inc: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 15: Assertio Therapeutics Inc: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 16: Assertio Therapeutics Inc: News and Events Summary
Table 17: Assertio Therapeutics Inc: Business Expansion
Table 18: Assertio Therapeutics Inc: Corporate Governance
Table 19: Assertio Therapeutics Inc: Financial Performance
Table 20: Assertio Therapeutics Inc: Regulatory and Legal Events
Table 21: Assertio Therapeutics Inc: Research & Development

★海外企業調査レポート[Assertio Therapeutics Inc：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Nordstrom Inc (JWN)：企業の財務・戦略的SWOT分析
    Nordstrom Inc (JWN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • iNova Pharmaceuticals (Australia) Pty Ltd：企業の戦略的SWOT分析
    iNova Pharmaceuticals (Australia) Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Immunogen, Inc.：企業の戦略・SWOT・財務分析
    Immunogen, Inc. - Strategy, SWOT and Corporate Finance Report Summary Immunogen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Laboratorios SALVAT SA：製薬・医療：M&Aディール及び事業提携情報
    Summary Laboratorios SALVAT SA (SALVAT) is a pharmaceutical company with focus on the development and commercialization of innovative medicines. The company manufactures drugs in various segments such as personal healthcare, digestive / metabolism, urological conditions, ophthalmological diseases, E …
  • SAE Towers Holdings LLC：企業の戦略的SWOT分析
    SAE Towers Holdings LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Anworth Mortgage Asset Corp (ANH)：企業の財務・戦略的SWOT分析
    Summary Anworth Mortgage Asset Corp (Anworth) is a financial service provider that provides mortgage real estate investment services. The company invests in mortgage-backed securities on a leveraged basis. It operates through agency credit-backed securities and non-agency credit-backed securities. A …
  • Indequity Group Limited：企業の戦略・SWOT・財務情報
    Indequity Group Limited - Strategy, SWOT and Corporate Finance Report Summary Indequity Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Premier Gold Mines Limited：企業の戦略・SWOT・財務情報
    Premier Gold Mines Limited - Strategy, SWOT and Corporate Finance Report Summary Premier Gold Mines Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Pacific Mutual Holding Company：企業の戦略的SWOT分析
    Pacific Mutual Holding Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • C3J Therapeutics Inc-製薬・医療分野：企業M&A・提携分析
    Summary C3J Therapeutics Inc (C3J), formerly C3 Jian Inc, is a clinical-stage biotechnology company which concentrates on the development and commercialization of targeted and pathogen specific, antimicrobials that treat and prevent diseases caused by microbial dysbiosis. Its pipeline product portfo …
  • Regeneron Pharmaceuticals Inc (REGN)：企業の製品パイプライン分析
    Summary Regeneron Pharmaceuticals Inc (Regeneron) discovers, develops, manufactures, and markets medicines for the treatment of serious medical conditions. Its marketed and pipeline products are focused on helping patients suffering with eye diseases, cancer, allergic and inflammatory diseases, meta …
  • REVA Medical Inc (RVA)：製品パイプライン分析
    Summary REVA Medical Inc (REVA) is a medical device company that develops minimally invasive medical devices. The company’s product includes bioresorbable polymers. Its bioresorbable polymers can be applied to a variety of medical applications. REVA’s fantom sirolimus-eluting bioresorbable scaffold …
  • Medical Developments International Ltd (MVP)：製薬・医療：M&Aディール及び事業提携情報
    Summary Medical Developments International Ltd (MDI) is a healthcare company that develops, manufactures and markets pain relief and respiratory medicine. The company provides products such as penthrox, asthma and COPD, medical devices and veterinary products. It offers asthma and COPD products whic …
  • Metropolitan Bank and Trust Company：企業の戦略・SWOT・財務情報
    Metropolitan Bank and Trust Company - Strategy, SWOT and Corporate Finance Report Summary Metropolitan Bank and Trust Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Cubic Corp (CUB)：企業の財務・戦略的SWOT分析
    Cubic Corp (CUB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Korea National Oil Corp：企業の戦略的SWOT分析
    Korea National Oil Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Tizona Therapeutics Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Tizona Therapeutics Inc (Tizona Therapeutics) is an immunology company which develops treatments for cancer and autoimmune disorders. Its lead product candidate anti-CD39 antibody inhibits the breakdown of excessive ATP released from dying tumor cells to immune suppressive adenosine leading …
  • Advanced Biological Laboratories SA-医療機器分野：企業M&A・提携分析
    Summary Advanced Biological Laboratories SA (ABL) is a healthcare information technology company that provides integrated software solutions for personalised medicine. The company’s products include improving disease management software, project management software, cumulative reporting and related …
  • Ferring International Center SA-製薬・医療分野：企業M&A・提携分析
    Summary Ferring International Center SA (Ferring) researches, develops and markets pharmaceutical products. The company offers pharmaceutical products in the fields of reproductive health, gastroenterology, endocrinology, urology and orthopedics. Some of the marketed products include Rekovelle (foll …
  • Smiths Medical-医療機器分野：企業M&A・提携分析
    Summary Smiths Medical, a division of Smiths Group Plc, is a clinically-focused company, which manufactures medical devices used in various therapeutic, diagnostic and surgical procedures with focus on vital care, safety devices and medication delivery areas. The company’s product line consists of a …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆